Navigation auf


Epidemiology, Biostatistics and Prevention Institute

Immunological Correlates of COVID-19 Severity

We will systematically investigate clinical and immunological responses in COVID-19 patients. Subsequently, these data will help us identify individuals at risk for severe disease and thus inform clinical decision-making, including the initiation of targeted anti-inflammatory or anti-viral treatments early in disease course. The in-depth understanding generated by our systems immunology approach will be key to understanding the immunopathogenesis of COVID-19. Our data will also be crucial for informing the development of targeted therapies and vaccines against SARS-CoV-2. Lastly, our results will guide future studies aimed at mechanistically characterizing key immunological steps of protective immunity against Coronaviruses.

Weiterführende Informationen


Onur Boyman (Project Leader)

Ulrike Held

Michael Krauthammer

Jakob Nielsson

Dominik Schaer

Reto Schüpbach

Alexandra Trkola

Annelies Zinkernagel


University Hospital of Zurich, Innovations-Pool